Acute haemodynamic effects of an inhaled prostacyclin analogue (iloprost) in patients with primary and secondary pulmonary hypertension;Inhalasjon av en prostasyklinanalog (iloprost) ved primær og sekundær pulmonal hypertensjon

Tidsskrift for den Norske Laegeforening

Volumn 121, Issue 10, 2001, Pages 1220-1223

  Andreassen, A K ^a   Madsen, S ^a   Kjekshus, J ^a   Simonsen, S ^a  

^a Hjertemedisinsk Avdeling   (Norway)

Author keywords

[No Author keywords available]

Indexed keywords

ILOPROST; PROSTACYCLIN DERIVATIVE;

ADULT; AGED; ARTICLE; BLOOD PRESSURE; CLINICAL ARTICLE; CONGESTIVE HEART FAILURE; CONTROLLED STUDY; DISEASE SEVERITY; DRUG ACTIVITY; DRUG SAFETY; DRUG TOLERABILITY; FEMALE; HEART CATHETERIZATION; HEART OUTPUT; HEART RATE; HEMODYNAMICS; HUMAN; LUNG VASCULAR RESISTANCE; LUNG WEDGE PRESSURE; MALE; PULMONARY HYPERTENSION;

ADMINISTRATION, INHALATION; ADULT; AGED; FEMALE; HEMODYNAMIC PROCESSES; HUMANS; HYPERTENSION, PULMONARY; ILOPROST; MALE; MIDDLE AGED; PLATELET AGGREGATION INHIBITORS; VASODILATOR AGENTS;

EID: 0035917712     PISSN: 00292001     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (19)

1. Primary pulmonary hypertension. A national prospective study
2. Survival in patients with primary pulmonary hypertension: Results from a national prospective registry
3. Pulmonary hypertension with special reference to the vasoconstrictive factor
4. Primary pulmonary hypertension
5. The effect of high doses of calcium-channel blockers on survival in primary pulmonary hypertension
6. Reduction in pulmonary vascular resistance with long-term epoprostenol (prostacyclin) therapy in primary pulmonary hypertension
7. Iloprost: A review of its pharmacodynamic and pharmacokinetic properties, and therapeutic potential in peripheral vascular disease, myocardial ischemia and extracorporal circulation procedures
8. An imbalance between the excretion of thromboxane and prostacyclin metabolites in pulmonary hypertension
9. Reduced expression of endothelial nitric oxide synthase in the lungs of patients with pulmonary hypertension
10. Expression of endothelin-1 in the lungs of patients with pulmonary hypertension
11. The acute administration of vasodilators in primary pulmonary hypertension
12. Primary pulmonary primary hypertension: Improved long-term effects and survival with continuous epoprostenol infusion
13. Primary pulmonary hypertension
14. Role of cAMP and calcium influx in endothelin-1-induced ANP release in rat cardiomyocytes
15. An evaluation of nebulized prostacyclin in patients with primary and secondary pulmonary hypertension
16. Inhaled iloprost to treat severe pulmonary hypertension
17. Inhaled prostacyclin and iloprost in severe pulmonary hypertension secondary to lung fibrosis
18. A comparison of the acute hemodynamic effects of inhaled nitric oxide and aerosolized iloprost in primary pulmonary hypertension
19. Long-term treatment of primary pulmonary hypertension with aerosolized iloprost, a prostacyclin analogue